메뉴 건너뛰기




Volumn 16, Issue 31, 2010, Pages 3475-3477

Current therapeutic strategies and future perspectives for the treatment of venous thromboembolism

Author keywords

Anticoagulation; Thrombolysis; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; DABIGATRAN; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; TINZAPARIN; WARFARIN;

EID: 78649942079     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210793563347     Document Type: Article
Times cited : (2)

References (26)
  • 24
    • 47149108319 scopus 로고    scopus 로고
    • Pharmacological strategies for inhibition of thrombin activity
    • Alban S. Pharmacological strategies for inhibition of thrombin activity. Curr Pharm Des 2008; 14(12): 1152-1175.
    • (2008) Curr Pharm Des , vol.14 , Issue.12 , pp. 1152-1175
    • Alban, S.1
  • 25
    • 47149094663 scopus 로고    scopus 로고
    • Anticoagulation in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary angiography and interventions
    • Joost A, Kurowski V, Radke PW. Anticoagulation in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary angiography and interventions. Curr Pharm Des 2008; 14(12): 1176-1185.
    • (2008) Curr Pharm Des , vol.14 , Issue.12 , pp. 1176-1185
    • Joost, A.1    Kurowski, V.2    Radke, P.W.3
  • 26
    • 27744470403 scopus 로고    scopus 로고
    • Pharmacology and clinical potential of direct thrombin inhibitors
    • Linkins LA, Weitz JI. Pharmacology and clinical potential of direct thrombin inhibitors. Curr Pharm Des 2005; 11(30): 3877-3884.
    • (2005) Curr Pharm Des , vol.11 , Issue.30 , pp. 3877-3884
    • Linkins, L.A.1    Weitz, J.I.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.